Limitation of infarct size in rabbit hearts by the novel adenosine receptor agonist AMP 579 administered at reperfusion

Journal of Molecular and Cellular Cardiology

Volumn 32, Issue 12, 2000, Pages 2339-2347

  Xu, Zhelong ^a   Yang, Xi Ming ^a   Cohen, Michael V ^a   Neumann, Till ^b   Heusch, Gerd ^a,b   Downey, James M ^a  

^a UNIVERSITY OF SOUTH ALABAMA COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF DUISBURG ESSEN   (Germany)

Author keywords

Cardioprotection; Leukocytes; Myocardial infarction; Myocardial ischemia

Indexed keywords

4 [7 [[1 [(3 CHLORO 2 THIENYL)METHYL]PROPYL]AMINO] 3H IMIDAZO[4,5 B]PYRIDIN 3 YL] N ETHYL 2,3 DIHYDROXYCYCLOPENTANECARBOXAMIDE; 8 (4 SULFOPHENYL)THEOPHYLLINE; ADENOSINE RECEPTOR; ADENOSINE RECEPTOR STIMULATING AGENT;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; DRUG RECEPTOR BINDING; FEMALE; HEART INFARCTION SIZE; HEART MUSCLE ISCHEMIA; HEART MUSCLE REPERFUSION; HEART PROTECTION; MALE; NONHUMAN; PRIORITY JOURNAL; RABBIT;

EID: 0034509373     PISSN: 00222828     EISSN: None     Source Type: Journal    
DOI: 10.1006/jmcc.2000.1264     Document Type: Article

References (25)

1. Myocardial protective effects of adenosine: Infarct size reduction with pretreatment and continued receptor stimulation during ischemia
2. 1-selective adenosine analogues protects the heart against infarction
3. Reduction of reperfusion injury in the canine preparation by intracoronary adenosine: Importance of the endothelium and the no-reflow phenomenon
4. Reduction of myocardial reperfusion injury by intravenous adenosine administered during the early reperfusion period
5. Administration of adenosine during reperfusion reduces injury of vascular endothelium and death of myocytes
6. Adenosine infusion during early reperfusion failed to limit myocardial in farct size in a collateral deficient species
7. Effect of adenosine therapy at reperfusion on myocardial infarct size in dogs
8. 2 receptor agonist AMP 579 in a porcine model of myocardial infarction
9. 2-receptor agonist AMP 579: Coronary hemodynamic and cardioprotective effects in the canine myocardium
10. 3 adenosine receptor activation attenuates neutrophil function and neutrophil-mediated reperfusion injury
11. Tetrazolium artifactually indicates superoxide dismutase-induced salvage in reperfused rabbit heart
12. Failure of N-2-mercaptopropionyl glycine to reduce myocardial infarction after 3 days of reperfusion in rabbits
13. Fostriecin, an inhibitor of protein phosphatase 2A, limits myocardial infarct size even when administered after onset of ischemia
14. Cyclosporine A limits myocardial infarct size even when administered after onset of ischemia
15. ATP-channel activation
16. 2-receptor agonists on myocardial reperfusion injury
17. Comparative study of AMP579 and adenosine in inhibition of neutrophil-mediated vascular and myocardial injury during 24 h of reperfusion
18. Amp579, an A1/A2A agonist, limits infarct size at reperfusion via a P42/P44 MAPK-dependent pathway
19. Preconditioning with ischemia: A delay of lethal cell injury in ischemic myocardium
20. 1 adenosine receptors in rabbit heart
21. Role of adenosine receptor activation in myocardial infarct size limitation by ischaemic preconditioning
22. ATP-sensitive potassium channels: A review of their cardioprotective pharmacology
23. Receptor-mediated reduction of myocardial infarct size and attenuated no-reflow by endogenous adenosine during ischemia and reperfusion
24. ATP channels